Carbetocin Versus Ergometrine in the Management of Atonic Post Partum Haemorrhage (PPH) in Women Delivered Vaginally

• Status: Unknown status
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: Female

Summary

200 women will be randomly divided into 2 equal groups using computer generated random numbers. Group 1 will receive Carbetocin 100 µgm (Pabal® Ferring, UK) and group 2 will receive ergometrine 0.5mg (methergin®, Novartis, Switzerland).

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Cairo University
• Treatments: Carbetocin; Ergonovine; Oxytocin

Criteria

Inclusion Criteria:

• Women with atonic PPH.

Exclusion Criteria:

• Gestational age <37 weeks.

• Hypertension.

• Preeclampsia.

• Cardiac, renal or liver diseases

• Epilepsy.

• Known hypersensitivity to Carbetocin